Comprehensive clinical management of hirsutism (Q33539381)

27 July 2017

1 reference

title

Comprehensive clinical management of hirsutism (English)

1 reference

27 July 2017

1 reference

Camil Castelo-Branco

1

0 references

author name string

María Jesús Cancelo

series ordinal

2

1 reference

27 July 2017

publication date

1 July 2010

1 reference

Gynecological Endocrinology

27 July 2017

published in

1 reference

27 July 2017

volume

26

1 reference

27 July 2017

issue

7

1 reference

27 July 2017

page(s)

484-493

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

27 July 2017

1 reference

The clinical evaluation of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Hirsutism secondary to topical testosterone: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Impact of phenytoin therapy on the skin and skin disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Electrolysis: observations from 13 years and 140,000 hours of experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Idiopathic hirsutism: excessive bodily and facial hair in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Medical treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Hormonal therapy in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Treatment of hirsutism with combined pill containing drospirenone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Progestogens with antiandrogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Clinical practice. Hormonal contraception in women of older reproductive age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Effect of oral versus transdermal steroidal contraceptives on androgenic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

A review of transdermal hormonal contraception : focus on the ethinylestradiol/norelgestromin contraceptive patch

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Spironolactone for hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Fulminant liver failure associated with flutamide therapy for hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Hepatotoxicity during low-dose flutamide treatment for hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Long-term safety and tolerability of flutamide for the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Relative safety and efficacy of finasteride for treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Effect of finasteride in idiopathic hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Low-dose (2.5 mg/day) finasteride treatment in hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Use of cyproterone acetate, finasteride, and spironolactone to treat idiopathic hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Managing Cutaneous Manifestations of Hyperandrogenic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513591003686353

10.3109/09513591003686353

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference